8.89 USD
↘ 0.01 (0.11%)PRE MARKET (AS OF 07:27 AM EDT)
Maravai LifeSciences Holdings, Inc. Class A Common Stock
MRVINASDAQ • USD
Market: OPEN
Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) is currently trading at $8.89. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, MRVI trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 26, 2026.
Open?$8.80
High?$9.06
Low?$8.80
Prev. Close?$8.90
Volume?12.3K
Avg. Volume?3.6M
VWAP?$8.89
Rel. Volume?0.00x
Bid / Ask
Bid?$8.87 × 100
Ask?$8.94 × 100
Spread?$0.07
Midpoint?$8.91
Valuation & Ratios
Market Cap?1.3B
Shares Out?149.0M
Float?123.2M
Float %?83.5%
P/E Ratio?N/A
P/B Ratio?6.48
EPS?-$0.52
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Address
10770 WATERIDGE CIRCLE SUITE 200
SAN DIEGO, CA 92121
Phone: (858) 546-0004
SAN DIEGO, CA 92121
Phone: (858) 546-0004
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?75
Momentum?50
Short Sent.?35
Piotroski F-Score?4/9Mixed
Altman Z-Score?3.13Safe
Confidence?66%Moderate
Short InterestElevated
Short % of Float?7.62%Elevated
Short Interest?9.4M
Days to Cover?4.6
Free Float123.2M
Avg Daily Volume2.0M
Settlement Date2026-08-14
Financial Health
Current Ratio?4.05Strong
Quick Ratio?2.98Strong
Cash Ratio?1.82Strong
Debt/Equity?0.86Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?6.48FAIR▾
Peers100
S&P29
P/S?6.35FAIR▾
Peers100
S&P20
P/FCF?N/A▾
EV/EBITDA?-65.7CHEAP▾
S&P97
EV/Sales?6.86HIGH▾
Peers100
S&P21
Returns & Efficiency
ROE?-37.8%WEAK▾
S&P3
ROA?-12.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-35108000
Enterprise Value?$1.4B
Fundamentals ratios updated end of day